United States· US:0456-2700_5da940bc-28c3-4e0c-ac51-912f8cc1beb1
AVYCAZ
A medicinal product containing ceftazidime; avibactam sodium, registered in United States by Allergan, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFTAZIDIME; AVIBACTAM SODIUM
- Manufacturer
- Allergan, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 9, 2026
Packs & prices · 2
- ndc11045627001010 VIAL, SINGLE-DOSE in 1 CARTON (0456-2700-10) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0456-2700-01)
- ndc110456-2700-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftazidime; avibactam sodium in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- SpainZAVICEFTA 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONPfizer Ireland Pharmaceuticals Unlimited Company
- FranceZAVICEFTA 2 g/0,5 g, poudre pour solution à diluer pour perfusionPFIZER IRELAND PHARMACEUTICALS (IRLANDE)
- United KingdomZavicefta 2g/0.5g powder for concentrate for solution for infusion vialsPfizer Ltd
- IrelandZavicefta 2 g/0.5 g powder for concentrate for solution for infusionPfizer Ireland Pharmaceuticals
- IcelandZaviceftaPfizer Ireland Pharmaceuticals
- NetherlandsZAVICEFTA 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusiePfizer Ireland Pharmaceuticals, Operations Services Group
- NorwayZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zavicefta
- Liechtenstein · Zavicefta
- Norway · Zavicefta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b02d9b32-c2ac-4955-9c40-a9db642a7411 GET /v1/drugs/b02d9b32-c2ac-4955-9c40-a9db642a7411?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": ".5; 2",
"substance": "CEFTAZIDIME; AVIBACTAM SODIUM",
"productndc": "0456-2700",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/1; g/1",
"application_number": "NDA206494",
"marketing_category": "NDA"
}See everything about ceftazidime; avibactam sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.